BamSEC and AlphaSense Join Forces
Learn More

Xeris Pharmaceuticals Inc – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-Q 2 pages Amendment 4 to the Quality Assurance Agreement
12/34/56
EX-10.3
from 10-Q 5 pages Quality Agreement Amendment Document: Qaa-Xeris Amendment1 Revision: 00 Date: 05/11/21 Replaces: N/a Page: 1 of 4 Pyramid Laboratories, Inc. Confidential Amendment Quality Agreement Qaa-Xeris Revision 03 Page 1 of 4 Quality Agreement History Page by and Between Contractor Name: Pyramid Laboratories, Inc. (Pli) and Client: Xeris Pharmaceuticals, Inc. Agreement Description: Aseptic Drug Product Manufacturing and Analytical Services Brief Description of Quality Agreement Revisions Section Number Effective Date Document No. Update of Appendix 1 for Contacts and Responsibilities Appendix 1 Effective as of Last Signatory Date Qaa-Xeris Revision 03
12/34/56
EX-10.2
from 10-Q 5 pages Document No: Revision: Revision Date: Replaces: Page: Msa-Xpi Amendment 2 05/13/21 00 3 of 4 Schedule a Batch Size, Dosage, Yield*, Volume, Pricing [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]
12/34/56
EX-10.2
from 8-K 11 pages Xeris Pharmaceuticals, Inc. Employment Agreement
12/34/56
EX-10.1
from 8-K 12 pages July 28, 2021 Dear Barry
12/34/56
EX-10.3
from 8-K 10 pages Deed of Irrevocable Undertaking
12/34/56
EX-10.2
from 8-K 10 pages Deed of Irrevocable Undertaking
12/34/56
EX-10.1
from 8-K 10 pages Deed of Irrevocable Undertaking
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to Api Supply Agreement
12/34/56
EX-10.1
from 8-K 23 pages Securities Purchase Agreement
12/34/56
EX-10.36
from 10-K 43 pages Amendment and Restatement to Quality Agreement
12/34/56
EX-10.1
from 8-K 13 pages Form of Exchange Agreement
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to the Employment Agreement Between John Shannon (“Executive”) and Xeris Pharmaceuticals, Inc
12/34/56
EX-10.2
from 10-Q 7 pages Recitals Terms and Conditions
12/34/56
EX-10.3
from 10-Q 4 pages Portions of This Exhibit Have Been Redacted Because They Are Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark "[***]". Amendment 3 to the Quality Assurance Agreement
12/34/56
EX-10.1
from 8-K 8 pages Silicon Valley Bank U.S. Small Business Administration Paycheck Protection Program Note
12/34/56
EX-10.1
from 8-K 11 pages Xeris Pharmaceuticals, Inc. Deferred Compensation Plan
12/34/56
EX-10.1
from 10-Q 6 pages Consulting Agreement
12/34/56
EX-10.22
from S-1 27 pages First Amendment to Office Lease Agreement
12/34/56
EX-10.13
from S-1 3 pages First Amendment to the Employment Agreement Between Beth P. Hecht (“Executive”) and Xeris Pharmaceuticals, Inc
12/34/56